Copyright Reports & Markets. All rights reserved.

Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size Growth Rate by Product
      • 1.4.2 Corticosteroids
      • 1.4.3 Serotonin Antagonists
      • 1.4.4 Dopamine Antagonists
      • 1.4.5 NK-1 Inhibitors
      • 1.4.6 Cannabinoids
      • 1.4.7 Motion Sickness Treatments
      • 1.4.8 Anti-Anxiety Drugs
      • 1.4.9 Other
    • 1.5 Market by End User
      • 1.5.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size Growth Rate by End User
      • 1.5.2 High Emetic Risk Intravenous Chemotherapy
      • 1.5.3 Moderate Emetic Risk Intravenous Chemotherapy
      • 1.5.4 Low and Minimal Emetic Risk Intravenous Chemotherapy
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size
      • 2.1.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue 2014-2025
      • 2.1.2 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales 2014-2025
    • 2.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Growth Rate by Regions
      • 2.2.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales by Regions
      • 2.2.2 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales by Manufacturers
      • 3.1.1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales by Manufacturers
      • 3.1.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Manufacturers
      • 3.1.3 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue by Manufacturers
      • 3.2.1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Manufacturers (2014-2019)
    • 3.3 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Price by Manufacturers
    • 3.4 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base Distribution, Product Types
      • 3.4.1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Type
      • 3.4.3 Date of International Manufacturers Enter into Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales by Product
    • 4.2 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue by Product
    • 4.3 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Breakdown Data by End User

    6 North America

    • 6.1 North America Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by Countries
      • 6.1.1 North America Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales by Countries
      • 6.1.2 North America Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by Product
    • 6.3 North America Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by End User

    7 Europe

    • 7.1 Europe Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by Countries
      • 7.1.1 Europe Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales by Countries
      • 7.1.2 Europe Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by Product
    • 7.3 Europe Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by Countries
      • 8.1.1 Asia Pacific Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales by Countries
      • 8.1.2 Asia Pacific Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by Product
    • 8.3 Asia Pacific Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by End User

    9 Central & South America

    • 9.1 Central & South America Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by Countries
      • 9.1.1 Central & South America Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales by Countries
      • 9.1.2 Central & South America Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by Product
    • 9.3 Central & South America Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by Countries
      • 10.1.1 Middle East and Africa Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales by Countries
      • 10.1.2 Middle East and Africa Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by Product
    • 10.3 Middle East and Africa Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs by End User

    11 Company Profiles

    • 11.1 GlaxoSmithKline Plc
      • 11.1.1 GlaxoSmithKline Plc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 GlaxoSmithKline Plc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 GlaxoSmithKline Plc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Products Offered
      • 11.1.5 GlaxoSmithKline Plc Recent Development
    • 11.2 Helsinn Group
      • 11.2.1 Helsinn Group Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Helsinn Group Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Helsinn Group Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Products Offered
      • 11.2.5 Helsinn Group Recent Development
    • 11.3 Heron Therapeutics
      • 11.3.1 Heron Therapeutics Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Heron Therapeutics Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Products Offered
      • 11.3.5 Heron Therapeutics Recent Development
    • 11.4 Merck & Co Inc
      • 11.4.1 Merck & Co Inc Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Merck & Co Inc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Merck & Co Inc Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Products Offered
      • 11.4.5 Merck & Co Inc Recent Development
    • 11.5 Tesaro
      • 11.5.1 Tesaro Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Tesaro Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Tesaro Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Products Offered
      • 11.5.5 Tesaro Recent Development

    12 Future Forecast

    • 12.1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Forecast by Regions
      • 12.1.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Regions 2019-2025
    • 12.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Forecast by Product
      • 12.2.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Product 2019-2025
      • 12.2.2 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Product 2019-2025
    • 12.3 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Forecast by End User
    • 12.4 North America Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Forecast
    • 12.5 Europe Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Forecast
    • 12.6 Asia Pacific Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Forecast
    • 12.7 Central & South America Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Forecast
    • 12.8 Middle East and Africa Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market based on company, product type, end user and key regions.

      This report studies the global market size of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs in these regions.
      This research report categorizes the global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market by top players/brands, region, type and end user. This report also studies the global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      GlaxoSmithKline Plc
      Helsinn Group
      Heron Therapeutics
      Merck & Co Inc
      Tesaro

      Market size by Product
      Corticosteroids
      Serotonin Antagonists
      Dopamine Antagonists
      NK-1 Inhibitors
      Cannabinoids
      Motion Sickness Treatments
      Anti-Anxiety Drugs
      Other
      Market size by End User
      High Emetic Risk Intravenous Chemotherapy
      Moderate Emetic Risk Intravenous Chemotherapy
      Low and Minimal Emetic Risk Intravenous Chemotherapy
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now